June 9/2015 FinanceLatest Pharma M&A Trends: Frenzy and Risks Escalate The pharma industry is making progress and going through a frenzy of activity on the strategic, business, M&A and financial fronts, writes Peter Young .../Read more/ |
||||||||
|
|
||||||||
| Europe A Regulatory Dark Horse? Cross-Border Patients’ Rights in Europe The European Union’s directive on patients’ rights in cross-border healthcare was seen as a bit of a damp squib when it was first adopted, but its importance is now coming into view, writes Reflector .../Read more/ |
||||||||
| Emerging Markets Bryan Spielman outlines why China is poised for a data renaissance—one that could play a pivotal role in the next wave of pharma innovation ... /Read more/ |
||||||||
| Event World Health Assembly Underlines Pharma's Global Challenges Susan Crowley reviews the hotly debated agenda items from May’s World Health Assembly (WHA) in Geneva, Switzerland .../Read more/ |
||||||||
| Event ASCO (American Society of Clinical Oncology): Highlights of 2015 Annual Meeting Casey McDonald presents some highlights from a blustery few days in Chicago, with immunotherapy and cost, predictably taking center stage .../Read more/ |
||||||||
industry update
|
 |
|
 |
|
|
|
 |
 |
 |
 |
 |
 |